ABSTRACT
Background and Purpose Following a hemiparetic stroke, prolonged altered motor neuron inputs may drive passive mechanical changes within muscle that further amplify brain injury induced motor impairments, reducing optimal recovery. However, due to confounding factors, i.e. muscle hypertonicity and spasticity, and the use of botulinum neurotoxin (BoNT), chemical denervation to reduce their expression, there is no consensus on how altered neural inputs following a stroke affect muscle passive mechanical properties or the extent to which these properties ultimately limit functional recovery. Therefore, the objective of this study is to quantify muscle passive biomechanical properties following chronic hemiparetic stroke and BoNT.
Methods Passive torques about the wrist and metacarpophalangeal (MCP) joints were quantified in both hands of 34 individuals with chronic hemiparetic stroke. Participants’ hand impairments ranged from severe to mild with a subset who previously received BoNT injections. Torques were quantified with subjects in a sleep or near-sleep state, mitigating muscle hyperactivity. EMGs were continuously monitored to ensure no muscle activity during data collection.
Results Participants who previously received BoNT injections demonstrated significantly greater passive flexion torques about their paretic wrist and fingers as compared to those who never received BoNT. As a result, only the group who received BoNT demonstrated significant decreases in passive MCP extension.
Conclusions The results of our thorough investigation of in vivo passive elastic torques at the wrist and fingers in chronic hemiparetic stroke contrast with the increased stiffness and decreased passive ROM observed clinically and in many previous studies. We highlight the need to effective address both stroke-induced muscle hyperactivity and BoNT treatment history as confounds. We conclude that loss of hand function post-stroke is predominantly due to motor impairments post stroke. Adverse effects of BoNT warrant consideration in future studies and rehabilitation interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a Promotion of Doctoral Studiese Level II Scholarship from the Foundation for Physical Therapy, American Heart Associatione Pre-Doctoral Fellowship: 16PRE30970010, National Institutes of Health (T32EB009406) to J.P.A.D., and National Institutes of Health Grant R01HD084009 to J.P.A.D. and W.M.M. (principal investigators).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data set used within this analysis is available by request from the authors.
